| |  | | | 
ARCHIVED INDUSTRY OUTREACH:
PRESENTATIONS / BOARDS
Immunologists Meeting
Drs. Katherine Wall and Marcia McInerney recently attended the annual meeting of the American Association of Immunologists, Experimental Biology 2004. Dr. Wall presented a talk and a poster titled, "Passive Experimental Autoimmune Myasthenia Gravis with Monoclonal Antibody 35 is Enhanced by Interleukin 12 and Requires Interferon Gamma." Co-authors on the paper were Sunghan Yim, Mariola Klis and Anthony Infante.
Japan Conference
Dr. James Slama, department of medicinal and biological chemistry, was one of 50 scientists worldwide invited to Japan in July for the 2004 Fujihara Conference on "New Challenges in Research on ADP-ribose Metabolism." Dr. Slama presented a poster and a talk on his recent research results titled, "Cyclic ADP-ribose Analogs" before the conference of international experts.
NIH Panelist
Dr. James Slama, department of medicinal and biological chemistry, recently served as an ad hoc member of a grant review panel for the National Institutes of Health Center for Scientific Review on Bioorganic and Natural Products Chemistry. The panel advised NIH on the scientific and technical merits of proposed research grants submitted to the agency in the subject of health related chemistry.
Mid-Atlantic Graduate Student Symposium
Dr. James Slama, department of medicinal and biological chemistry, led a group of graduate students to the 37th annual Mid-Atlantic Graduate Student Symposium in Medicinal Chemistry, MAGSS, in June at Purdue University. Toledo students attending included Ma’moun Al Hamedsheh, Schuchi Gupta, Greg White, and Yasser Heakal. Ma’moun, a PhD student in Dr. Richard Hudson’s lab, presented a talk on his work titled, "A New Series of Conformationally Restrained Epothilone Analogues," potentially valuable anti-cancer agents. Faculty and students also attended from Purdue University, University of Michigan, Ohio State University and Duquesne University.
From A to Zebrafish
Toni Aloia, a Master’s student in the laboratory of Frederick E. Williams Ph.D. in the Department of Pharmacology, presented a poster entitled "Zebrafish embryos as a model to study developmental toxicity related to thimerosol exposure" at the 6th International Zebrafish Conference in Madison, Wisconsin. Dr. Williams was co-author on the paper.
Sean Renock, a Master’s student in the laboratory of Frederick E. Williams Ph.D. in the Department of Pharmacology, presented a poster entitled "Development of a transgenic fish line for the study of the muscarinic acetylcholine receptor hM1 in the development of Danio rerio" at the 6th International Zebrafish Conference in Madison, Wisconsin. Dr. Williams co-authored the paper.
Frederick E. Williams, Ph.D., from the Department of Pharmacology, presented a poster entitled "Modulation by ellagic acid of DCA induced developmental defects and oxidative stress in Danio rerio" at the 6th International Zebrafish Conference in Madison, Wisconsin. Co-authors were Ezdihar Hassoun, Ph.D. of the Department of Pharmacology, and Traci Sickelbaugh, M.S. who recently graduated from Dr. Williams’ laboratory.
Alumna Leads Discussions at AAPS
University of Toledo College of Pharmacy alumna Dr. Sheela (Sitaraman) Das ’98 has been named Chair-elect of the Indianapolis-Cincinnati Discussion Group of the American Association of Pharmaceutical Scientists (AAPS). Dr. Das earned a Ph.D. in Medicinal Chemistry from UT after several years in Dr. Katherine Wall’s laboratory. Dr. Das is a Senior Analytical Chemist in Drug Disposition at Eli Lilly and Company.
Informing the IUPAC
Dr. Paul Erhardt, Professor and Director of the Center for Drug Design and Development at The University of Toledo (UT) College of Pharmacy, attended the International Union of Pure and Applied Chemistry (IUPAC) Div. VII Subcommittee meeting on Medicinal Chemistry and Drug Development in March in Anaheim, CA. He gave three presentations on his IUPAC-sponsored projects pertaining to "A Compendium of Drug Metabolism Terms;" "A Human Drug Metabolism Database (hDMdb)" and "IUPAC Survey and Discussion Group on Present Trends in Patenting Drug-Related Technologies."
Leading an Alternative Spring Break
Dr. Martin Ohlinger, Assistant Professor of Pharmacy Practice at The University of Toledo College of Pharmacy (UTCP), was the Mexico Trip Leader for Toledo Campus Ministry’s Alternative Spring Break. He led students to help underserved residents of Piedras Negras, Mexico with the global outreach ministry Volunteers In Mission. UTCP student Andrew Davidson was among the team, while UTCP student Melissa Summers traveled with another group to build a Habitat for Humanity home in Birmingham, Alabama.
Alumni & Faculty: Presence & Recognition
University of Toledo College of Pharmacy faculty members Martin Ohlinger, Steve Martin and Sandy Close and several alumni attended the Society of Critical Care Medicine (SCCM) Annual Congress in February. Alumni Christine Ahrens ‘01, Andreea Popa ’02 and Nadine Chehab ‘02 shared poster presentations. Alumna Sandy Kane-Gill ‘98 was named Chair-Elect of the society’s Clinical Pharmacy and Pharmacology (CPP) section. Kane-Gill, Martin and Ohlinger received Presidential Citations.
Pfizer/UTCP CE a Success
More than 70 area pharmacists attended a successful Pharmacist-Patient Consultation Program in February at the Student Union. The College of Pharmacy partnered with Pfizer to offer the free seminar to Ohio and Michigan UT alumni and local retail and institutional pharmacists. Dr. Susan Cornell of Midwestern University, Chicago College of Pharmacy, led the workshop. Participants enjoyed breakfast and lunch and earned three ACPE credits.
Faculty Senate Approves New Academic Performance Standards
At the January 2004 University of Toledo (UT) Faculty Senate meeting, the senators approved a new set of academic performance standards for students entering the UT College of Pharmacy beginning Fall 2004. Under the previous policy, a GPA of 2.7 or better was required for admission to the professional division. The revised policy mandates that students in the professional division of the PharmD program maintain a 3.0 GPA and earn a "C" or better in core-curriculum courses.
Preclinical Development Forum
Dr. Paul Erhardt, Professor and Director of the Center for Drug Design and Development at The University of Toledo College of Pharmacy, presented at the IBC Preclinical Development Forum in Boston. His lecture, titled, "Phase 0: Not At All Nothing During Clinical Drug Metabolism," drew a full house of recognized experts in the fields associated with drug discovery, development and early clinical testing.
A New Campus Landmark -- Pharmacy Plaza
The University of Toledo Facilities Planning Council has recommended to the Executive Cabinet that the outdoor space in front of Wolfe Hall be named "Pharmacy Plaza" or a similar name to be determined by the College. The naming is not restricted to the Centennial year 2004. The recommendation is for a permanent naming, but is subject to renaming at any time should a valid donation opportunity arise. Upon the Executive Cabinet’s approval, it will be determined if the naming requires Board approval.
AACP Committee
Dr. Richard Hudson, of The University of Toledo College of Pharmacy’s Medicinal and Biological Chemistry Department, recently served on an AACP committee on pharmacogenomics. A white paper was developed and published in JAPE in late 2002. Pharmacogenomics is a marriage of pharmaceutical sciences with genetics, aiming in part to use human genetic information to develop strategies for individualizing drug therapies. According to Dr. Hudson, "a major goal of the committee was to develop and suggest strategies for changes in both educational and research directions at colleges of pharmacy to accommodate the development of pharmacogenomics."
Scientific Advisory Boards
Dr. Paul Erhardt, Professor and Director of the Center for Drug Design and Development at The University of Toledo (UT) College of Pharmacy, has been invited to join the Scientific Advisory Board (SAB) of ARYx, a start-up company in Santa Clara, CA that specializes in soft drug (metabolism) technologies.
Dr. Erhardt is a member of the Scientific Advisory Board of ComGenex, a company in Budapest specializing in directed combinatorial libraries and chemo-informatic products, including a drug metabolism database. He continues as a member of the SAB of Toledo’s Cognitive Pharmaceuticals, a company based on UT-derived technologies. He also serves on the Society of Biomolecular Screening’s Academic Outreach Committee.
President of IUPAC Division VII
Dr. Paul Erhardt, Professor and Director of the Center for Drug Design and Development at The University of Toledo College of Pharmacy, attended back-to-back IUPAC Division VII and IUPAC Medicinal Chemistry Subcommittee business meetings in London on December 12 and 13. He will assume the Presidency of IUPAC Division VII--Chemistry and Human Health--in 2004 for a term of four years.
Soybean Research Collaboration
Drs. Paul Erhardt and Jeff Sarver, on behalf of the Center for Drug Design and Development at The University of Toledo College of Pharmacy, initiated and participated in a research collaboration meeting in New Orleans on November 15-19. This developing collaboration stems from USDA funding to conduct basic research on soybeans. It involves Tulane and Xavier Universities as well as the Southern Regional US Agricultural Research Station in New Orleans.
Lecture and Recruitment Presentation
Dr. Paul Erhardt, Professor and Director of the Center for Drug Design and Development at The University of Toledo (UT) College of Pharmacy, was recently invited to deliver a technical lecture and a graduate student recruitment presentation for UT’s Medicinal Chemistry and Biology Department to the Chemistry Department at Oakland University in Michigan.
Grant Review Panel
Dr. Paul Erhardt, Professor and Director of the Center for Drug Design and Development at The University of Toledo College of Pharmacy, participated in a National Institutes of Health Study Section grant review panel in Washington DC in November. This SSS-L panel evaluates SBIR and STTR grant applications pertaining to drug discovery and development.
Autumn Immunology Conference
Sunghan Yim and Mohammad Mohammad, graduate students with The University of Toledo (UT) College of Pharmacy’s Medicinal and Biological Chemistry Department, joined faculty members Dr. Marcia McInerney and Dr. Katherine Wall recently to present posters and workshop talks at the 32nd Annual Autumn Immunology Conference in Chicago. The meeting brought together immunology researchers from throughout the Midwest to present recent research results and to update their knowledge of immunology. Dr. Anthony Quinn, of UT’s Biological Sciences Department, also participated.
Autumn Immunology Conference
Visit our Newsroom page for current information. ...More
|
| | |
